Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLAG Antikörper

Der Maus Monoklonal Anti-HLAG Antikörper wurde für FACS validiert. Er ist geeignet, HLAG in Proben von Human zu detektieren.
Produktnummer ABIN7670065

Kurzübersicht für HLAG Antikörper (ABIN7670065)

Target

Alle HLAG Antikörper anzeigen
HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

Reaktivität

  • 156
  • 7
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 110
  • 51
  • 3
  • 1
  • 1
Maus

Klonalität

  • 114
  • 52
Monoklonal

Konjugat

  • 106
  • 17
  • 15
  • 11
  • 6
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser HLAG Antikörper ist unkonjugiert

Applikation

  • 63
  • 59
  • 52
  • 46
  • 26
  • 23
  • 13
  • 12
  • 10
  • 6
  • 6
  • 6
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Klon

MEM-G-11
  • Verwendungszweck

    Purified Anti-Human HLA-G Antibody[MEM-G/11]

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    ≥ 1 mg/mL

    Buffer

    Phosphate buffered solution, pH 7.2, containing 0.05 % proclin 300.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    avoid freeze / thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.

    Haltbarkeit

    12 months
  • Target

    HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

    Andere Bezeichnung

    HLA-G

    Hintergrund

    HLA,MHC-G,HLA-G,HLA-G HLA-6.0 HLAG,HLA-G5,HLA-6.0,HLAG,alpha chain G,B2 microglobulin,class I,DADB-15K14.8,HLA 6.0,HLA class I histocompatibility antigen,HLA class I histocompatibility antigen alpha chain G,HLA class I molecule,HLA G,HLA G antigen,HLA G histocompatibility antigen class I G,HLA G3,HLA60,HLA-G histocompatibility antigen,Major histocompatibility complex class I G,MHC class I antigen,MHC class I antigen G,MHC G,TCA,T-cell A locus,HLA-G Antibody (4H84) is an IgG1 κ mouse monoclonal HLA-G antibody (also designated HLA major histocompatibility complex, class I, G antibody, human leukocyte antigen (HLA) G antibody, 45 kDa transmembrane class I human leukocyte antigen G antibody, chromosome 6p22 gene complex class 1G antibody, placenta trophoblast marker antibody, or fetal derived placental cell marker antibody) that detects the HLA-G protein of mouse, rat and human origin by WB, IP, IF and IHC(P). HLA-G Antibody (4H84) is available as both the non-conjugated anti-HLA-G antibody form, as well as multiple conjugated forms of anti-HLA-G antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Major histocompatibility complex (MHC), human leukocyte antigen (HLA) molecules are cell-surface receptors that bind foreign peptides and present them to T lymphocytes. MHC class I molecules consist of two polypeptide chains, an α or heavy chain, and a non-covalently associated protein, β-2-microglobulin. Cytotoxic T lymphocytes bind antigenic peptides presented by MHC class I molecules. Antigens that bind to MHC class I molecules are typically 8-10 residues in length and are stabilized in a peptide binding groove. MHC class II molecules are encoded by polymorphic MHC genes and consist of a non-covalent complex of an a and b chain. Helper T lymphocytes bind antigenic peptides presented by MHC class II molecules. MHC class II molecules bind 13-18 amino acid antigenic peptides. Accumulating in endosomal/lysosomal compartments and on the surface of B cells, HLA-DM and -DO molecules regulate binding of exogenous peptides to class II molecules (HLA-DR) by sustaining a conformation that favors peptide exchange. The differential structural properties of MHC class I and class II molecules account for their respective roles in activating different populations of T lymphocytes.

    UniProt

    P17693

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Chat with us!